Molecular genotyping in a malaria treatment trial in Uganda - Unexpected high rate of new infections within 2 weeks after treatment

Tropical Medicine and International Health

Volumn 12, Issue 2, 2007, Pages 219-223

  Mugittu, Kefas ^a,f   Priotto, Gerardo ^b   Guthmann, Jean Paul ^b   Kiguli, James ^c   Adjuik, Martin ^d   Snounou, Georges ^e   Beck, Hans Peter ^f   Mshinda, Hassan ^a   Olliaro, Piero L ^g   Taylor, Walter R J ^g,h  

^a IFAKARA HEALTH INSTITUTE   (Tanzania)

^b EPICENTRE   (France)

^c MBARARA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Uganda)

^d NAVRONGO HEALTH RESEARCH CENTRE   (Ghana)

^e MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

^f SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^g WORLD HEALTH ORGANIZATION   (Switzerland)

^h OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

Author keywords

Combination therapy; Genotyping; Malaria; Plasmodium Falciparum; Re infections; Recrudescent; Uganda

Indexed keywords

ARTESUNATE; GLUTAMIC ACID; MEROZOITE SURFACE PROTEIN 1; MEROZOITE SURFACE PROTEIN 2; PLACEBO; PYRIMETHAMINE; SULFADOXINE;

DISEASE TRANSMISSION; DISEASE TREATMENT; GENETIC ANALYSIS; GENOTYPE; MALARIA; MOLECULAR ANALYSIS; POLYMERASE CHAIN REACTION;

ANTIMALARIAL ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FOLLOW UP; GENE AMPLIFICATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MEROZOITE; MOLECULAR GENETICS; PARASITEMIA; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; REINFECTION; RESISTANCE MANAGEMENT; UGANDA;

ANIMALS; ANTIMALARIALS; ARTEMISININS; CHILD; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; ENDEMIC DISEASES; GENES, PROTOZOAN; GENOTYPE; HUMANS; MALARIA, FALCIPARUM; MEROZOITE SURFACE PROTEIN 1; PARASITEMIA; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PROTOZOAN PROTEINS; PYRIMETHAMINE; RECURRENCE; SESQUITERPENES; SULFADOXINE; UGANDA;

AFRICA; EAST AFRICA; MBARARA; SOUTHERN PROVINCE [UGANDA]; SUB-SAHARAN AFRICA; UGANDA;

ARTESUNATE; PLASMODIUM FALCIPARUM;

EID: 33846999932     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2007.01813.x     Document Type: Article

References (23)

1. Adjuik M, Agnamey P, Babiker A et al. (2002) Amodiaquine- artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomized, multicentre trial. Lancet 359, 1365-1372.
2. Adjuik M, Babiker A & Garner P et al. (2004) Artesunate combinations for treatment of malaria: meta-analysis. Lancet 363, 9-17.
3. Basco LK & Ringwald P (2000) Molecular epidemiology of malaria in Younde, Cameroon. VII. Analysis of recrudescence and re-infection in patients with uncomplicated falciparum malaria. American Journal of Tropical Medicine and Hygiene 63, 215-221.
4. Basco LK, Ndounga M, Keundjian A & Ringwald P (2002) Molecular epidemiology of malaria in Cameroon. XI. Characteristics of recrudescent and persistent Plasmodium falciparum infections after chloroquine or amodiaquine treatment in children. American Journal of Tropical Medicine and Hygiene 66, 117-123.
5. Brockman A, Paul REL, Anderson TJC et al. (1999) Application of genetic markers in the identification of recrudescent Plasmodium falciparum infections on the Northwestern border of Thailand. American Journal of Tropical Medicine and Hygiene 60, 14-21.
6. Cattamanchi A, Kyabayinze D, Hubbard A, Rosenthal PJ & Dorsey G(2003) Distinguishing recrudescence from re-infection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of MSP-1, MSP-2, and GLURP. American Journal of Tropical Medicine and Hygiene 68, 133-139.
7. Farnert A & Bjorkman A (2005) Limited advantage of multiple consecutive samples for genotyping Plasmodium falciparum populations during the first days of treatment. American Journal of Tropical Medicine and Hygiene 73, 204-206.
8. Felger I, Tavul L, Kabintik S et al. (1994) Plasmodium falciparum: extensive polymorphism in merozoite surface antigen 2 alleles in an area with endemic malaria in Papua New Guinea. Experimental Parasitology 79, 106-116.
9. Gil VS, Ferreira MRC & d'Alva FSM et al. (2003) Efficacy of artesunate plus chloroquine for uncomplicated malaria in children in Sao Tomé: a double-blind randomised controlled trial. Transactions of the Royal Society of Tropical Medicine and Hygiene 97, 703-706.
10. Happi CT, Gbotosho GO, Sowunmi A et al. (2004) Molecular analysis of Plasmodium falciparum recrudescent malaria infections in children treated with chloroquine in Nigeria. American Journal of Tropical Medicine and Hygiene 70, 20-26.
11. Irion A, Felger I, Abdulla S et al. (1998) Distinction of recrudescences from new infections by PCR-RFLP analysis in a comparative trial of CGP 56 697 and chloroquine in Tanzanian children. Tropical Medicine and International Health 3, 490-497.
12. Magesa SM, Mdira KY, Farnert A, Simionsen PE, Bygbjerg IC & Jakobsen PH (2001) Distinguishing Plasmodium falciparum treatment failures from re-infections by using polymerase chain reaction genotyping in a holoendemic area in Northeastern Tanzania. American Journal of Tropical Medicine and Hygiene 65, 477-483.
13. Obonyo OC, Ochieng F & Taylor WRJ et al. (2003) Artesunate plus sulfadoxine-pyrimethamine for uncomplicated malaria in Kenyan children: a randomized, double blind, placebo- controlled trial. Transactions of the Royal Society of Tropical Medicine and Hygiene 97, 585-591.
14. Priotto G, Kabakyenga J & Pinoges L et al. (2003) Artesunate and sulfadoxine-pyrimethamine combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Uganda: a randomized, double-blind, placebo-controlled trial. Transactions of the Royal Society of Tropical Medicine and Hygiene 97, 325-330.
15. Ranford-Cartwright LC, Taylor J, Umasunthar L et al. (1997) Molecular analysis of recrudescent parasites in a Plasmodium falciparum drug trial in Gabon. Transactions of the Royal Society of Tropical Medicine and Hygiene 91, 719-724.
16. von Seidlein L, Milligan P, Pinder M et al. (2000) Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial. Lancet 355, 352-357.
17. Sirima SB, Tiono AB, Konate A et al. (2003) Efficacy of artesunate plus chloroquine for the treatment of uncomplicated malaria in children in Burkina Faso: a double-blind, randomized, controlled trial. Transactions of the Royal Society of Tropical Medicine and Hygiene 97, 345-349.
18. Snounou G & Beck H-P (1998) The use of PCR genotyping in the assessment of recrudescence or re-infection after antimalarial drug treatment. Parasitology Today 14, 462-467.
19. Snounou G, Zhu X, Siripoon N et al. (1999) Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum population in Thailand. Transactions of the Royal Society of Tropical Medicine and Hygiene 93, 369-374.
20. White NJ (1998) Why is it that antimalarial drug treatments do not always work? Annals of Tropical Medicine and Parasitology 92, 449-458.
21. WHO (1973) Chemotherapy of Malaria and Resistance to Antimalarials. World Health Organization Technical Reports Series 529, Geneva.
22. WHO (2003) Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated Falciparum Malaria. WHO/HTM/RBM/2003.50. World Health Organization, Geneva.
23. WHO (2006) Guidelines for the Treatment of Malaria. World Health Organization, Geneva.